AB154 Combined With AB122 for Recurrent Glioblastoma
Clinical trial NCT04656535 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04656535
- Sponsor
- Yale University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-21
- Primary completion
- 2026-03-17
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.